This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Aazami, R. Search for Related Content Social Bookmarking                         What's this?

Initial Appraisal of Acute Coronary Syndromes

Department of Pharmacy Services, Cedars-Sinai Medical Center, Los Angeles, California, aazamir{at}cshs.org

Acute coronary syndrome remains a daunting health care problem in the United States. One third of emergency department patients with chest pain will eventually have a diagnosis of acute coronary syndrome. During the past decade, there have been many advances in the treatment of acute coronary syndrome as well as a widespread movement in emergency medicine to streamline the process of its treatment. Goals of emergency department care include rapid identification of patients with acute myocardial infarction, exclusion of causes of nonischemic chest pain, stratification of patients with acute coronary ischemia into low-risk and high-risk groups, and initiation of pharmacologic treatments. These goals will be discussed in this review, with particular emphasis on pharmacologic treatments.

Key Words: Acute coronary syndromes • pathogenesis • clinical presentation • risk stratification • pharmacologic treatment

Journal of Pharmacy Practice, Vol. 18, No. 5, 377-393 (2005)
DOI: 10.1177/0897190005280045


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?